我国基本药物制度监测评价现状研究  

Study on the Monitoring and Evaluation Situation of National Essential Medicine System

作　　者：余华[1] 肖草茂[1] 胡小平[1] 贾立明[2] 廖立华[2] 王丹[1] 刘一超[1] 利家平[1] 张文辉[2] 

机构地区：[1]江西省药物研究所,南昌330029 [2]江西省卫生厅,南昌330046

出　　处：《中国药房》2013年第28期2593-2595,共3页China Pharmacy

基　　金：卫生部药政司资助项目

摘　　要：目的:为完善基本药物制度监测评价工作机制提供参考。方法:采用文献检索、问卷调查以及实地调研等方法,研究我国部分省、自治区、直辖市基本药物制度监测评价现状。结果与结论:我国大多数省、自治区、直辖市已开展了基本药物制度监测评价工作,并取得了初步成效,初步建立了基本药物制度监测评价政策体系,较为全面地掌握了基本药物制度实施进展,并及时反映了实施过程中的困难、问题及其原因,为完善国家基本药物制度相关政策提供了科学依据。但同时也存在基本药物制度监测评价组织体系尚不完整、经费尚无保障、硬件条件尚不具备、数据尚不准确等问题。OBJECTIVE： To provide reference for the improvement of monitoring and evaluation mechanism of essential medi- cine system and the effects of essential medicine system. METHODS. By literature review, questionnaire survey and field investiga- tion, the monitoring and evaluation situation of national essential medicine system were evaluated in some province. RESULTS ＆ CONCLUSIONS： Majority of provinces （autonomous regions and municipalities） have carried out the monitoring and evaluation of essential medicine system, and have made some achievements; the policy system of monitoring and evaluation has been established initially, and the implementation of the essential medicine system has been mastered comprehensively; the difficulties, problems and reasons of the implementation has been analyzed timely to provide scientific evidence for the improvement of essential medi- cine system. However, there are also some issues, such as incomplete organizational system, inadequate working expenses, unqual- ified hardware conditions and inaccurate data of monitoring and evaluation.

关 键 词：基本药物制度 监测 评价 现状 

分 类 号：R95[医药卫生—药学]